Phibro Animal Health Corp (NASDAQ:PAHC) to Issue $0.12 Quarterly Dividend


Phibro Animal Health Corp (NASDAQ:PAHC) announced a quarterly dividend on Monday, November 4th, Zacks reports. Shareholders of record on Wednesday, November 27th will be given a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 annualized dividend and a yield of 1.98%. The ex-dividend date is Tuesday, November 26th.

PAHC stock opened at $24.26 on Friday. The stock has a market capitalization of $988.27 million, a P/E ratio of 18.51, a P/E/G ratio of 6.93 and a beta of 0.87. The company has a debt-to-equity ratio of 1.84, a current ratio of 3.21 and a quick ratio of 1.77. Phibro Animal Health has a 1-year low of $20.00 and a 1-year high of $36.98. The business has a fifty day moving average price of $22.87 and a 200-day moving average price of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.05). Phibro Animal Health had a net margin of 4.99% and a return on equity of 25.52%. The company had revenue of $190.00 million for the quarter, compared to the consensus estimate of $199.22 million. During the same period in the prior year, the firm posted $0.39 EPS. The business’s revenue for the quarter was down 5.0% on a year-over-year basis. As a group, analysts anticipate that Phibro Animal Health will post 1.1 earnings per share for the current year.

A number of equities analysts have recently weighed in on PAHC shares. Bank of America dropped their price objective on Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating for the company in a research note on Thursday, August 29th. Credit Suisse Group reissued a “neutral” rating and set a $25.00 price target (down from $31.00) on shares of Phibro Animal Health in a research note on Wednesday, August 28th. BidaskClub raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Morgan Stanley raised Phibro Animal Health from an “underweight” rating to an “equal” rating and increased their price target for the company from $21.00 to $30.00 in a research note on Thursday, September 5th. They noted that the move was a valuation call. Finally, Barclays dropped their price target on Phibro Animal Health from $25.00 to $18.00 and set an “underweight” rating for the company in a research note on Thursday, August 29th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Phibro Animal Health currently has an average rating of “Hold” and an average target price of $26.60.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

See Also: Short Selling

Dividend History for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phibro Animal Health and related companies with’s FREE daily email newsletter.


Please enter your comment!
Please enter your name here